NCT03515174
- Conditions
- Cancer, Carcinoma, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- National Cancer Centre Singapore Singapore
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,018 public trials
2,029 recruiting studies
Immunoproliferative Disorders trial results
NCT05190068
- Conditions
- B-cell Non-Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Beijing Chao-Yang Hospital, Capital Medical University Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Xiamen University Xiameng, Fujian, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
- Guangxi Medical University cancer Hospital & Guangxi Cancer Institute Nanning, Guangxi, China
NCT04317066
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Nagoya University Hospital ( Site 0002) Nagoya, Aichi-ken, Japan
- Hokkaido University Hospital ( Site 0006) Sapporo, Hokkaido, Japan
- Kindai University Hospital ( Site 0001) Sayama, Osaka, Japan
- National Hospital Organization Disaster Medical Center ( Site 0007) Tachikawa, Tokyo, Japan
Completed
Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma
NCT04849351
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- The Second Hospital of Anhui Medical University Hefei, Anhui, China
- Beijing Chao-yang Hospital, Capital Medical University Beijing, Beijing Municipality, China
- Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
- Peking University Third Hospital Beijing, Beijing Municipality, China
NCT03755414
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +18 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT03311958
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
NCT02616965
- Conditions
- Cutaneous T-cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University of Pennsylvania, Perelman Center Philadelphia, Pennsylvania, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
NCT04105010
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Yale Cancer Center New Haven, Connecticut, United States
- Winship Cancer Institute Atlanta, Georgia, United States
- Washington University School of Medicine St Louis, Missouri, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
Completed
CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma
NCT04758767
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- CHU de Nantes - Hôpital Hôtel-Dieu Nantes, France
- CHU Rennes - Pontchaillou Rennes, France
- Gustave Roussy Cancer Center Villejuif, France
- Sarah Cannon London, United Kingdom
NCT00588991
- Conditions
- Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, +55 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States